{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T04:47:40Z","timestamp":1790484460792,"version":"4.1.0"},"reference-count":148,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Magnetic Diagnostic Assay","award":["732678 SEP 210349930"],"award-info":[{"award-number":["732678 SEP 210349930"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.bbadis.2019.165584","type":"journal-article","created":{"date-parts":[[2019,10,29]],"date-time":"2019-10-29T02:59:51Z","timestamp":1572317991000},"page":"165584","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["N-terminal tau truncation in the pathogenesis of Alzheimer's disease (AD): Developing a novel diagnostic and therapeutic approach"],"prefix":"10.1016","volume":"1866","author":[{"given":"G.","family":"Amadoro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Latina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Corsetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Calissano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2019.165584_bb0005","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.pharep.2014.09.004","article-title":"Ekavali, A review on Alzheimer\u2019s disease pathophysiology and its management: an update","volume":"67","author":"Kumar","year":"2015","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.bbadis.2019.165584_bb0010","doi-asserted-by":"crossref","first-page":"15056","DOI":"10.1038\/nrdp.2015.56","article-title":"Alzheimer\u2019s disease","volume":"1","author":"Masters","year":"2015","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.bbadis.2019.165584_bb0015","first-page":"209","article-title":"Histopathological criteria for progressive dementia disorders: clinical-pathological correlation and classification by multivariate data analysis, Acta Neuropathol","volume":"74","author":"Alafuzoff","year":"1987","journal-title":"74"},{"key":"10.1016\/j.bbadis.2019.165584_bb0020","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1212\/WNL.42.3.631","article-title":"Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer\u2019s disease","volume":"42","author":"Arriagada","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2019.165584_bb0025","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/ana.10161","article-title":"Alzheimer\u2019s neurofibrillary pathology and the spectrum of cognitive function: findings from the Nun study","volume":"51","author":"Riley","year":"2002","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbadis.2019.165584_bb0030","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.cell.2012.02.040","article-title":"Alzheimer mechanisms and therapeutic strategies","volume":"148","author":"Huang","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2019.165584_bb0035","doi-asserted-by":"crossref","unstructured":"P. Sharma, P. Srivastava, A. Seth, P.N. Tripathi, A.G. Banerjee, S.K. Shrivastava, Comprehensive review of mechanisms of pathogenesis involved in Alzheimer's disease and potential therapeutic strategies, Prog. Neurobiol. (2018) pii: S0301-0082(18)30139-4, doi: https:\/\/doi.org\/10.1016\/j.pneurobio.2018.12.006.","DOI":"10.1016\/j.pneurobio.2018.12.006"},{"key":"10.1016\/j.bbadis.2019.165584_bb0040","doi-asserted-by":"crossref","first-page":"595","DOI":"10.15252\/emmm.201606210","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease at 25 years","volume":"8","author":"Selkoe","year":"2016","journal-title":"EMBO. Mol. Med."},{"key":"10.1016\/j.bbadis.2019.165584_bb0045","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/NEN.0b013e31825018f7","article-title":"Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature","volume":"71","author":"Nelson","year":"2012","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.bbadis.2019.165584_bb0050","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1523\/JNEUROSCI.2028-17.2017","article-title":"Entorhinal tau pathology, episodic memory decline, and neurodegeneration in aging","volume":"38","author":"Maass","year":"2018","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2019.165584_bb0055","doi-asserted-by":"crossref","unstructured":"A. Bejanin, D.R. Schonhaut, R. La Joie, J.H. Kramer, S.L. Baker, N. Sosa, N. Ayakta, A. Cantwell, M. Janabi, M. Lauriola, J.P. O'Neil, M.L. Gorno-Tempini, Z.A. Miller, H.J. Rosen, B.L. Miller, W.J. Jagust, G.D. Rabinovici, Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer's disease, Brain 140 (2017) 3286\u20133300, doi: https:\/\/doi.org\/10.1093\/brain\/awx243.","DOI":"10.1093\/brain\/awx243"},{"key":"10.1016\/j.bbadis.2019.165584_bb0060","doi-asserted-by":"crossref","unstructured":"M.E. Murray, V.J. Lowe, N.R. Graff-Radford, A.M. Liesinger, A. Cannon, S.A. Przybelski, B. Rawal, J.E. Parisi, R.C. Petersen, K. Kantarci, O.A. Ross, R. Duara, D.S. Knopman, C.R. Jr Jack, D.W. Dickson, Clinicopathologic and 11C-Pittsburgh compound B implications of Thal amyloid phase across the Alzheimer's disease spectrum, Brain 138 (2015) 1370\u20131381, doi: https:\/\/doi.org\/10.1093\/brain\/awv050.","DOI":"10.1093\/brain\/awv050"},{"key":"10.1016\/j.bbadis.2019.165584_bb0065","doi-asserted-by":"crossref","first-page":"6364","DOI":"10.1073\/pnas.092136199","article-title":"Tau is essential to beta -amyloid-induced neurotoxicity","volume":"99","author":"Rapoport","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2019.165584_bb0070","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1126\/science.1141736","article-title":"Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model","volume":"316","author":"Roberson","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2019.165584_bb0075","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1083\/jcb.200605187","article-title":"Tau-dependent microtubule disassembly initiated by prefibrillar beta-amyloid, J","volume":"175","author":"King","year":"2006","journal-title":"Cell. Biol."},{"key":"10.1016\/j.bbadis.2019.165584_bb0080","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1126\/science.1194653","article-title":"Tau reduction prevents Abeta-induced defects in axonal transport","volume":"330","author":"Vossel","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2019.165584_bb0085","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1523\/JNEUROSCI.2610-10.2011","article-title":"Tau protein is required for amyloid {beta}-induced impairment of hippocampal long-term potentiation","volume":"31","author":"Shipton","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2019.165584_bb0090","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.cell.2010.06.036","article-title":"Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models","volume":"142","author":"Ittner","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2019.165584_bb0095","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1111\/ejn.12504","article-title":"Tau acts as a mediator for Alzheimer\u2019s disease-related synaptic deficits","volume":"39","author":"Liao","year":"2014","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.bbadis.2019.165584_bb0100","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.tins.2017.04.002","article-title":"Synaptic impairment in Alzheimer\u2019s disease: a dysregulated symphony","volume":"40","author":"Forner","year":"2017","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.bbadis.2019.165584_bb0105","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.neuron.2014.05.004","article-title":"The intersection of amyloid beta and tau at synapses in Alzheimer's disease","volume":"82","author":"Spires-Jones","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.bbadis.2019.165584_bb0110","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1474-4422(13)70090-5","article-title":"Tau pathology and neurodegeneration","volume":"12","author":"Spillantini","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bbadis.2019.165584_bb0115","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13041-017-0298-7","article-title":"Propagation of tau aggregates","volume":"10","author":"Goedert","year":"2017","journal-title":"Mol. Brain"},{"key":"10.1016\/j.bbadis.2019.165584_bb0120","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.tips.2017.03.011","article-title":"Brief overview of tauopathy: causes, consequences","volume":"38","author":"Orr","year":"2017","journal-title":"And Therapeutic Strategies, Trends Pharmacol. Sci."},{"key":"10.1016\/j.bbadis.2019.165584_bb0125","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.3233\/JAD-132054","article-title":"Intracellular and extracellular roles for tau in neurodegenerative disease","volume":"40","author":"Hanger","year":"2014","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbadis.2019.165584_bb0130","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s40478-017-0488-7","article-title":"What is the evidence that tau pathology spreads through prion-like propagation?","volume":"5","author":"Mudher","year":"2017","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.bbadis.2019.165584_bb0135","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.jalz.2016.06.006","article-title":"Therapeutic strategies for the treatment of tauopathies: hopes and challenges","volume":"12","author":"Khanna","year":"2016","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.bbadis.2019.165584_bb0140","doi-asserted-by":"crossref","first-page":"798","DOI":"10.3389\/fnins.2018.00798","article-title":"Ten years of tau-targeted immunotherapy: the path walked and the roads ahead","volume":"12","author":"Novak","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.bbadis.2019.165584_bb0145","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.molmed.2015.03.003","article-title":"Tau immunotherapy for Alzheimer's disease","volume":"21","author":"Pedersen","year":"2015","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.bbadis.2019.165584_bb0150","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3233\/JAD-2008-15202","article-title":"Immunotherapy targeting pathological tau protein in Alzheimer's disease and related tauopathies","volume":"15","author":"Sigurdsson","year":"2008","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbadis.2019.165584_bb0155","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1159\/000440842","article-title":"Tau immunotherapy","volume":"16","author":"Sigurdsson","year":"2016","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.bbadis.2019.165584_bb0160","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/alzrt214","article-title":"Propagation of tau pathology in Alzheimer\u2019s disease: identification of novel therapeutic targets","volume":"5","author":"Pooler","year":"2013","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.bbadis.2019.165584_bb0165","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3233\/JAD-140267","article-title":"CSF levels of a 20-22kDa NH2-fragment of human tau provide a novel neuronal injury biomarker in Alzheimer\u2019s disease and other dementias","volume":"42","author":"Amadoro","year":"2014","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbadis.2019.165584_bb0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0076523","article-title":"Characterization of novel CSF tau and ptau biomarkers for Alzheimer\u2019s disease","volume":"8","author":"Meredith","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2019.165584_bb0175","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.neurobiolaging.2014.09.007","article-title":"Human secreted tau increases amyloid-b production","volume":"36","author":"Bright","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbadis.2019.165584_bb0180","article-title":"Novel tau fragments in cerebrospinal fluid: relation to tangle pathology and cognitive decline in Alzheimer's disease","author":"Cicognola","year":"2018","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbadis.2019.165584_bb0185","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1021\/acs.jproteome.5b01001","article-title":"Tau protein quantification in human cerebrospinal fluid by targeted mass spectrometry at high sequence coverage provides insights into its primary structure heterogeneity","volume":"15","author":"Barth\u00e9lemy","year":"2016","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.bbadis.2019.165584_bb0190","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.3233\/JAD-150962","article-title":"Differential mass spectrometry profiles of tau protein in the cerebrospinal fluid of patients with Alzheimer\u2019s disease, progressive Supranuclear palsy, and dementia with Lewy bodies","volume":"51","author":"Barth\u00e9lemy","year":"2016","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbadis.2019.165584_bb0195","doi-asserted-by":"crossref","first-page":"6084","DOI":"10.1523\/JNEUROSCI.4261-13.2014","article-title":"Activity-dependent tau protein translocation to excitatory synapse is disrupted by exposure to amyloid-beta oligomers","volume":"34","author":"Frandemiche","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2019.165584_bb0200","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/nrneurol.2017.162","article-title":"Amyloid-\u03b2 and tau complexity - towards improved biomarkers and targeted therapies","volume":"14","author":"Polanco","year":"2010","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.bbadis.2019.165584_bb0205","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s40478-017-0489-6","article-title":"Atypical, non-standard functions of the microtubule associated tau protein","volume":"5","author":"Sotiropoulos","year":"2017","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.bbadis.2019.165584_bb0210","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.neuron.2010.11.030","article-title":"Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration","volume":"68","author":"Hoover","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.bbadis.2019.165584_bb0215","doi-asserted-by":"crossref","unstructured":"H-C. Tai, B.Y. Wang, A. Serrano Pozo, M.P. Frosch, T.L. Spires-Jones, B.T. Hyman, Frequent and symmetric deposition of misfolded tau oligomers within presynaptic and postsynaptic terminals in Alzheimer's disease, Acta Neuropathol. Commun. 2 (2014) 146, doi: https:\/\/doi.org\/10.1186\/s40478-014-0146-2.","DOI":"10.1186\/PREACCEPT-9134577561374599"},{"key":"10.1016\/j.bbadis.2019.165584_bb0220","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.neuroscience.2016.03.044","article-title":"Tau pathology-mediated presynaptic dysfunction","volume":"325","author":"Moreno","year":"2016","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbadis.2019.165584_bb0225","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1177\/1073858416633439","article-title":"Physiological and pathophysiological implications of synaptic tau","volume":"23","author":"Regan","year":"2017","journal-title":"Neuroscientist"},{"key":"10.1016\/j.bbadis.2019.165584_bb0230","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.neurobiolaging.2004.09.019","article-title":"Tau truncation during neurofibrillary tangle evolution in Alzheimer's disease","volume":"26","author":"Guillozet-Bongaarts","year":"2005","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbadis.2019.165584_bb0235","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3233\/JAD-2008-14407","article-title":"Truncation of tau protein and its pathological significance in Alzheimer's disease","volume":"14","author":"Garc\u00eda-Sierra","year":"2008","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbadis.2019.165584_bb0240","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.neuint.2010.12.023","article-title":"Post-translational modifications of tau protein: implications for Alzheimer's disease","volume":"58","author":"Martin","year":"2011","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.bbadis.2019.165584_bb0245","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1172\/JCI200420640","article-title":"Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology","volume":"114","author":"Rissman","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2019.165584_bb0250","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1097\/NEN.0b013e31817275c7","article-title":"Accumulation of aspartic acid421- and glutamic acid391-cleaved tau in neurofibrillary tangles correlates with progression in Alzheimer disease","volume":"67","author":"Basurto-Islas","year":"2008","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.bbadis.2019.165584_bb0255","doi-asserted-by":"crossref","first-page":"10032","DOI":"10.1073\/pnas.1630428100","article-title":"Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimer\u2019s disease","volume":"100","author":"Gamblin","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2019.165584_bb0260","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0002-9440(10)63317-2","article-title":"Active caspase-6 and caspase-6-cleaved tau in neuropil threads, neuritic plaques, and neurofibrillary tangles of Alzheimer's disease","volume":"165","author":"Guo","year":"2004","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbadis.2019.165584_bb0265","doi-asserted-by":"crossref","first-page":"7895","DOI":"10.1523\/JNEUROSCI.1988-04.2004","article-title":"Early N-terminal changes and caspase-6 cleavage of tau in Alzheimer's disease","volume":"24","author":"Horowitz","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2019.165584_bb0270","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1242\/jcs.113.21.3737","article-title":"C-terminal inhibition of tau assembly in vitro and in Alzheimer\u2019s disease","volume":"113","author":"Abraha","year":"2000","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bbadis.2019.165584_bb0275","doi-asserted-by":"crossref","first-page":"8325","DOI":"10.1021\/bi027348m","article-title":"Inhibition of tau polymerization by its carboxy-terminal caspase cleavage fragment","volume":"42","author":"Berry","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbadis.2019.165584_bb0280","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.febslet.2005.11.077","article-title":"C-terminal truncation modulates both nucleation and extension phases of tau fibrillization","volume":"580","author":"Yin","year":"2006","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbadis.2019.165584_bb0285","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s00401-017-1707-9","article-title":"Roles of tau protein in health and disease","volume":"133","author":"Guo","year":"2017","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbadis.2019.165584_bb0290","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1038\/nature08890","article-title":"Caspase activation precedes and leads to tangles","volume":"464","author":"de Calignon","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2019.165584_bb0295","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1042\/BST0380955","article-title":"Proteolytic processing of tau","volume":"38","author":"Wang","year":"2010","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.bbadis.2019.165584_bb0300","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1038\/nm.4199","article-title":"Caspase-2 cleavage of tau reversibly impairs memory","volume":"22","author":"Zhao","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbadis.2019.165584_bb0305","doi-asserted-by":"crossref","unstructured":"L. Zhou, J. Mcinnes, K. Wierda, M. Holt, A.G. Herrmann, R.J. Jackson, Y.C. Wang, J. Swerts, J. Beyens, K. Miskiewicz, S. Vilain, I. Dewachter, D. Moechars, B. De Strooper, T.L. Spires-Jones, J. De Wit, P. Verstreken, Tau association with synaptic vesicles causes presynaptic dysfunction, Nat. Commun. 8 (2017) 15295, doi: https:\/\/doi.org\/10.1038\/ncomms15295.","DOI":"10.1038\/ncomms15295"},{"key":"10.1016\/j.bbadis.2019.165584_bb0310","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s40478-015-0193-3","article-title":"Pro-aggregant tau impairs mossy fiber plasticity due to structural changes and Ca++ dysregulation","volume":"3","author":"Decker","year":"2015","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.bbadis.2019.165584_bb0315","doi-asserted-by":"crossref","unstructured":"G. Amadoro, V. Corsetti, A. Atlante, F. Florenzano, S. Capsoni, R. Bussani, D. Mercanti, P. Calissano, Interaction between NH2-tau fragment and A\u00df in AD mitochondria contributes to the synaptic deterioration, Neurobiol. Aging 33 (2012) 833.e1-25, doi: https:\/\/doi.org\/10.1016\/j.neurobiolaging.2011.08.001.","DOI":"10.1016\/j.neurobiolaging.2011.08.001"},{"key":"10.1016\/j.bbadis.2019.165584_bb0320","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3233\/JAD-170959","article-title":"Tau proteolysis in the pathogenesis of tauopathies: neurotoxic fragments and novel biomarkers","volume":"63","author":"Quinn","year":"2018","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbadis.2019.165584_bb0325","doi-asserted-by":"crossref","first-page":"3709","DOI":"10.1097\/00001756-199712010-00010","article-title":"Co-localization of truncated tau and DNA fragmentation in Alzheimer's disease neurones","volume":"8","author":"Ugolini","year":"1997","journal-title":"Neuroreport"},{"key":"10.1016\/j.bbadis.2019.165584_bb0330","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1006\/nbdi.2000.0335","article-title":"Proapoptotic effects of tau cleavage product generated by caspase-3","volume":"8","author":"Chung","year":"2001","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbadis.2019.165584_bb0335","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1046\/j.1471-4159.2000.0750624.x","article-title":"The neuronal microtubule-associated protein tau is a substrate for caspase-3 and an effector of apoptosis","volume":"75","author":"Fasulo","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2019.165584_bb0340","doi-asserted-by":"crossref","first-page":"437","DOI":"10.2174\/156720506779025242","article-title":"Pathways by which Abeta facilitates tau pathology","volume":"3","author":"Blurton-Jones","year":"2006","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.bbadis.2019.165584_bb0345","doi-asserted-by":"crossref","unstructured":"Y. Chen, A.K.Y. Fu, N.Y. Ip. Synaptic dysfunction in Alzheimer's disease: Mechanisms and therapeutic strategies, Pharmacol. Ther. (2018) pii: S0163-7258(18)30203-1, doi: https:\/\/doi.org\/10.1016\/j.pharmthera.2018.11.006.","DOI":"10.1016\/j.pharmthera.2018.11.006"},{"key":"10.1016\/j.bbadis.2019.165584_bb0350","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.neuroscience.2012.05.050","article-title":"Synaptic changes in Alzheimer's disease and its models","volume":"251","author":"Pozueta","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbadis.2019.165584_bb0355","doi-asserted-by":"crossref","first-page":"18670","DOI":"10.1073\/pnas.1006586107","article-title":"Early deficits in synaptic mitochondria in an Alzheimer\u2019s disease mouse model","volume":"107","author":"Du","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2019.165584_bb0360","article-title":"Mitochondrial dysfunction contributes to the pathogenesis of Alzheimer\u2019s disease","volume":"509654","author":"Cabezas-Opazo","year":"2015","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.bbadis.2019.165584_bb0365","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.cell.2004.11.003","article-title":"The importance of dendritic mitochondria in the morphogenesis and plasticity of spines and synapses","volume":"119","author":"Li","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2019.165584_bb0370","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3389\/fnsyn.2010.00139","article-title":"Synaptic mitochondria in synaptic transmission and organization of vesicle pools in health and disease","volume":"2","author":"Vos","year":"2010","journal-title":"Front. Synaptic Neurosci."},{"key":"10.1016\/j.bbadis.2019.165584_bb0375","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.3233\/JAD-160726","article-title":"Mitochondrial aspects of synaptic dysfunction in Alzheimer\u2019s disease","volume":"57","author":"Cai","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbadis.2019.165584_bb0380","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuropharm.2013.09.018","article-title":"A role for tau at the synapse in Alzheimer's disease pathogenesis","volume":"76","author":"Pooler","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbadis.2019.165584_bb0385","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.brainres.2011.07.052","article-title":"Abnormal tau, mitochondrial dysfunction, impaired axonal transport of mitochondria, and synaptic deprivation in Alzheimer's disease","volume":"1415","author":"Reddy","year":"2011","journal-title":"Brain Res."},{"key":"10.1016\/j.bbadis.2019.165584_bb0390","doi-asserted-by":"crossref","first-page":"7061","DOI":"10.1523\/JNEUROSCI.18-18-07061.1998","article-title":"Tau cleavage and dephosphorylation in cerebellar granule neurons undergoing apoptosis","volume":"18","author":"Canu","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2019.165584_bb0395","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.mcn.2008.03.011","article-title":"Identification of a caspase-derived N-terminal tau fragment in cellular and animal Alzheimer's disease models","volume":"38","author":"Corsetti","year":"2008","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.bbadis.2019.165584_bb0400","doi-asserted-by":"crossref","first-page":"6826","DOI":"10.1073\/pnas.97.12.6826","article-title":"Alzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice","volume":"97","author":"Capsoni","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2019.165584_bb0405","doi-asserted-by":"crossref","first-page":"12432","DOI":"10.1073\/pnas.192442999","article-title":"Nerve growth factor and galantamine ameliorate early signs of neurodegeneration in anti-nerve growth factor mice","volume":"99","author":"Capsoni","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2019.165584_bb0410","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1006\/mcne.2002.1163","article-title":"Beta-amyloid plaques in a model for sporadic Alzheimer's disease based on transgenic anti-nerve growth factor antibodies","volume":"21","author":"Capsoni","year":"2002","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.bbadis.2019.165584_bb0415","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1523\/JNEUROSCI.5620-07.2008","article-title":"Lack of pathology in a triple transgenic mouse model of Alzheimer's disease after overexpression of the anti-apoptotic protein Bcl-2","volume":"28","author":"Rohn","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2019.165584_bb0420","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1385\/CBB:39:3:249","article-title":"Tipping the apoptotic balance in Alzheimer's disease: the abortosis concept","volume":"39","author":"Raina","year":"2003","journal-title":"Cell Biochem. Biophys."},{"key":"10.1016\/j.bbadis.2019.165584_bb0425","doi-asserted-by":"crossref","first-page":"163","DOI":"10.4161\/cib.7704","article-title":"Apoptosis and in vitro Alzheimer disease neuronal models","volume":"2","author":"Calissano","year":"2009","journal-title":"Commun. Integr. Biol."},{"key":"10.1016\/j.bbadis.2019.165584_bb0430","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1007\/s11064-014-1454-4","article-title":"Apoptosis in Alzheimer's disease: an understanding of the physiology, pathology and therapeutic avenues","volume":"39","author":"Obulesu","year":"2014","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.bbadis.2019.165584_bb0435","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/jnc.12967","article-title":"P301L tau expression affects glutamate release and clearance in the hippocampal trisynaptic pathway","volume":"132","author":"Hunsberger","year":"2015","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2019.165584_bb0440","doi-asserted-by":"crossref","first-page":"552","DOI":"10.15252\/embr.201541439","article-title":"The tau\/A152T mutation, a risk factor for frontotemporal-spectrum disorders, leads to NR2B receptor-mediated excitotoxicity","volume":"17","author":"Decker","year":"2016","journal-title":"EMBO Rep."},{"key":"10.1016\/j.bbadis.2019.165584_bb0445","doi-asserted-by":"crossref","unstructured":"E.D. Roberson, B. Halabisky, J.W. Yoo, J. Yao, J. Chin, F. Yan, T. Wu, P. Hamto, N. Devidze, G.Q. Yu, J.J. Palop, J.L. Noebels, L. Mucke, Amyloid-\u03b2\/Fyn-induced synaptic, network, and cognitive impairments depend on tau levels in multiple mouse models of Alzheimer's disease, J. Neurosci. 31 (2011) 700\u2013711, doi: https:\/\/doi.org\/10.1523\/JNEUROSCI.4152-10.2011.","DOI":"10.1523\/JNEUROSCI.4152-10.2011"},{"key":"10.1016\/j.bbadis.2019.165584_bb0450","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/sj.cdd.4401314","article-title":"Role of N-terminal tau domain integrity on the survival of cerebellar granule neurons","volume":"11","author":"Amadoro","year":"2004","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bbadis.2019.165584_bb0455","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1073\/pnas.0511065103","article-title":"NMDA receptor mediates tau-induced neurotoxicity by calpain and ERK\/MAPK activation","volume":"103","author":"Amadoro","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2019.165584_bb0460","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.bbabio.2008.07.004","article-title":"A peptide containing residues 26-44 of tau protein impairs mitochondrial oxidative phosphorylation acting at the level of the adenine nucleotide translocator","volume":"1777","author":"Atlante","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2019.165584_bb0465","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.bbabio.2013.04.001","article-title":"Dissecting the molecular mechanism by which NH2htau and A\u03b21-42 peptides impair mitochondrial ANT-1 in Alzheimer disease","volume":"1827","author":"Bobba","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2019.165584_bb0470","doi-asserted-by":"crossref","unstructured":"G. Amadoro, V. Corsetti, A. Stringaro, M. Colone, S. D'Aguanno, G. Meli, M. Ciotti, G. Sancesario, A. Cattaneo, R. Bussani, D. Mercanti, P. Calissano, A NH2 tau fragment targets neuronal mitochondria at AD synapses: possible implications for neurodegeneration, J. Alzheimers Dis. 21 (2010) 445\u2013470, doi: https:\/\/doi.org\/10.3233\/JAD-2010-100120.","DOI":"10.3233\/JAD-2010-100120"},{"key":"10.1016\/j.bbadis.2019.165584_bb0475","doi-asserted-by":"crossref","unstructured":"G. Amadoro, V. Corsetti, F. Florenzano, A. Atlante, M.T. Ciotti, M.P. Mongiardi, R. Bussani, V. Nicolin, S.L. Nori, M. Campanella, P. Calissano, AD-linked, toxic NH2 human tau affects the quality control of mitochondria in neurons, Neurobiol. Dis. 62 (2014b) 489\u2013507, Corrigendum in Neurobiol. Dis. 74C (2014b) 102\u2013103, doi: 10.1016\/j.nbd.2013.10.018.","DOI":"10.1016\/j.nbd.2014.11.010"},{"key":"10.1016\/j.bbadis.2019.165584_bb0480","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1093\/hmg\/ddv059","article-title":"NH2-truncated human tau induces deregulated mitophagy in neurons by aberrant recruitment of Parkin and UCHL-1: implications in Alzheimer's disease","volume":"24","author":"Corsetti","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2019.165584_bb0485","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1006\/taap.1999.8717","article-title":"Impaired glutamate clearance as a consequence of energy failure caused by MPP(+) in astrocytic cultures","volume":"158","author":"Di Monte","year":"1999","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.bbadis.2019.165584_bb0490","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/j.neurobiolaging.2007.12.005","article-title":"Mitochondrial dysfunction: an early event in Alzheimer pathology accumulates with age in AD transgenic mice","volume":"30","author":"Hauptmann","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbadis.2019.165584_bb0495","doi-asserted-by":"crossref","first-page":"20057","DOI":"10.1073\/pnas.0905529106","article-title":"Amyloid-beta and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer\u2019s disease mice","volume":"106","author":"Rhein","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2019.165584_bb0500","doi-asserted-by":"crossref","first-page":"887","DOI":"10.3233\/JAD-121711","article-title":"Early selective vulnerability of synapses and synaptic mitochondria in the hippocampal CA1 region of the Tg2576 mouse model of Alzheimer's disease","volume":"34","author":"Balietti","year":"2013","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbadis.2019.165584_bb0505","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s00401-018-1903-2","article-title":"Region-specific depletion of synaptic mitochondria in the brains of patients with Alzheimer's disease","volume":"136","author":"Pickett","year":"2018","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbadis.2019.165584_bb0510","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1179\/016164103101201995","article-title":"Cerebrometabolic abnormalities in Alzheimer's disease","volume":"25","author":"Blass","year":"2003","journal-title":"Neurol. Res."},{"key":"10.1016\/j.bbadis.2019.165584_bb0515","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.bbadis.2011.10.011","article-title":"Abnormal mitochondrial dynamics and synaptic degeneration as early events in Alzheimer's disease: implications to mitochondria-targeted antioxidant therapeutics","volume":"1822","author":"Reddy","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2019.165584_bb0520","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.3233\/JAD-160702","article-title":"Mitochondrial dysfunction and synaptic transmission failure in Alzheimer\u2019s disease","volume":"57","author":"Guo","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbadis.2019.165584_bb0525","doi-asserted-by":"crossref","first-page":"20797","DOI":"10.1074\/jbc.M111.234674","article-title":"Amyloid beta-mediated cell death of cultured hippocampal neurons reveals extensive tau fragmentation without increased full-length tau phosphorylation","volume":"286","author":"Reifert","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2019.165584_bb0530","doi-asserted-by":"crossref","first-page":"20315","DOI":"10.1074\/jbc.M601016200","article-title":"ERK1\/2 activation mediates Abeta oligomer-induced neurotoxicity via caspase-3 activation and tau cleavage in rat organotypic hippocampal slice cultures","volume":"281","author":"Chong","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2019.165584_bb0535","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.nbd.2013.10.019","article-title":"Endogenous murine tau promotes neurofibrillary tangles in 3xTg-AD mice without affecting cognition","volume":"62","author":"Baglietto-Vargas","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbadis.2019.165584_bb0540","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1016\/j.neurobiolaging.2013.05.010","article-title":"Impact of N-tau on adult hippocampal neurogenesis, anxiety","volume":"34","author":"Prister\u00e0","year":"2013","journal-title":"and memory, Neurobiol. Aging"},{"key":"10.1016\/j.bbadis.2019.165584_bb0545","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.neuroscience.2014.06.017","article-title":"Neuronal degeneration, synaptic defects, and behavioral abnormalities in tau\u2084\u2085\u208b\u2082\u2083\u2080 transgenic mice","volume":"275","author":"Lang","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbadis.2019.165584_bb0550","doi-asserted-by":"crossref","first-page":"667","DOI":"10.3389\/fnins.2017.00667","article-title":"Extracellular tau and its potential role in the propagation of tau pathology","volume":"11","author":"Yamada","year":"2017","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.bbadis.2019.165584_bb0555","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.neurobiolaging.2012.05.003","article-title":"Calcium phosphatase calcineurin influences tau metabolism","volume":"34","author":"Karch","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbadis.2019.165584_bb0560","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/embor.2013.15","article-title":"Physiological release of endogenous tau is stimulated by neuronal activity","volume":"14","author":"Pooler","year":"2013","journal-title":"EMBO Rep."},{"key":"10.1016\/j.bbadis.2019.165584_bb0565","doi-asserted-by":"crossref","first-page":"10851","DOI":"10.1523\/JNEUROSCI.0387-15.2015","article-title":"C-terminally truncated forms of tau, but not full-length tau or its C-terminal fragments, are released from neurons independently of cell death","volume":"35","author":"Kanmert","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2019.165584_bb0570","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.nbd.2012.05.021","article-title":"Constitutive secretion of tau protein by an unconventional mechanism","volume":"48","author":"Chai","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbadis.2019.165584_bb0575","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1016\/j.celrep.2018.04.056","article-title":"Unconventional secretion mediates the trans-cellular spreading of tau","volume":"23","author":"Katsinelos","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbadis.2019.165584_bb0580","doi-asserted-by":"crossref","first-page":"42751","DOI":"10.1074\/jbc.M112.380642","article-title":"Extracellular tau levels are influenced by variability in tau that is associated with tauopathies","volume":"287","author":"Karch","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2019.165584_bb0585","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.celrep.2018.04.040","article-title":"Extracellular forms of A\u03b2 and tau from iPSC models of Alzheimer\u2019s disease disrupt synaptic plasticity","volume":"23","author":"Hu","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbadis.2019.165584_bb0590","doi-asserted-by":"crossref","first-page":"13110","DOI":"10.1523\/JNEUROSCI.2569-11.2011","article-title":"In vivo microdialysis reveals age-dependent decrease of brain interstitial fluid tau levels in P301S human tau transgenic mice","volume":"31","author":"Yamada","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2019.165584_bb0595","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1093\/brain\/awr286","article-title":"Tau elevations in the brain extracellular space correlate with reduced amyloid-\u03b2 levels and predict adverse clinical outcomes after severe traumatic brain injury","volume":"135","author":"Magnoni","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.bbadis.2019.165584_bb0600","doi-asserted-by":"crossref","unstructured":"M. Novak, R. Jakes, P.C. Edwards, C. Milstein, C.M. Wischik, Difference between the tau protein of Alzheimer paired helical filament core and normal tau revealed by epitope analysis of monoclonal antibodies 423 and 7.51, Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 5837\u20135841.","DOI":"10.1073\/pnas.88.13.5837"},{"key":"10.1016\/j.bbadis.2019.165584_bb0605","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3389\/fnagi.2018.00027","article-title":"Relevance of phosphorylation and truncation of tau to the etiopathogenesis of Alzheimer\u2019s disease","volume":"10","author":"Zhou","year":"2018","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.bbadis.2019.165584_bb0610","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1046\/j.1471-4159.1997.68010430.x","article-title":"The tau protein in human cerebrospinal fluid in Alzheimer's disease consists of proteolytically derived fragments","volume":"68","author":"Johnson","year":"1997","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2019.165584_bb0615","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1021\/pr7008669","article-title":"Characterization of tau in cerebrospinal fluid using mass spectrometry","volume":"7","author":"Portelius","year":"2008","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.bbadis.2019.165584_bb0620","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1136\/jnnp-2014-308004","article-title":"Divergent CSF tau alterations in two common tauopathies: Alzheimer\u2019s disease and progressive supranuclear palsy","volume":"86","author":"Wagshal","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.bbadis.2019.165584_bb0625","doi-asserted-by":"crossref","unstructured":"Z. Chen, D. Mengel, A. Keshavan, R.A. Rissman, A. Billinton, M. Perkinton, J. Percival-Alwyn, A. Schultz, M. Properzi, K. Johnson, D.J. Selkoe, R.A. Sperling, P. Patel, H. Zetterberg, D. Galasko, J.M. Schott, D.M. Walsh, Learnings about the complexity of extracellular tau aid development of a blood-based screen for Alzheimer's disease, Alzheimers Dement. (2018) pii: S1552\u20135260(18)33561\u20131, doi: https:\/\/doi.org\/10.1016\/j.jalz.2018.09.010.","DOI":"10.1016\/j.jalz.2018.09.010"},{"key":"10.1016\/j.bbadis.2019.165584_bb0630","doi-asserted-by":"crossref","unstructured":"C. Sato, N.R. Barth\u00e9lemy, K.G. Mawuenyega, B.W. Patterson, B.A. Gordon, J. Jockel-Balsarotti, M. Sullivan, M.J. Crisp, T. Kasten, K.M. Kirmess, N.M. Kanaan, K.E. Yarasheski, A. Baker-Nigh, T.L.S. Benzinger, T.M. Miller, C.M. Karch, R.J. Bateman, Tau kinetics in neurons and the human central nervous system, Neuron 97 (2018) 1284\u20131298.e7, doi: https:\/\/doi.org\/10.1016\/j.neuron.2018.02.015.","DOI":"10.1016\/j.neuron.2018.02.015"},{"key":"10.1016\/j.bbadis.2019.165584_bb0635","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/jnc.12991","article-title":"Pre-synaptic C-terminal truncated tau is released from cortical synapses in Alzheimer\u2019s disease","volume":"133","author":"Sokolow","year":"2015","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2019.165584_bb0640","doi-asserted-by":"crossref","first-page":"8124","DOI":"10.1007\/s12035-018-0974-3","article-title":"AD-related N-terminal truncated tau is sufficient to recapitulate in vivo the early perturbations of human neuropathology: implications for immunotherapy","volume":"55","author":"Borreca","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bbadis.2019.165584_bb0645","doi-asserted-by":"crossref","first-page":"64745","DOI":"10.18632\/oncotarget.17371","article-title":"Extracellular truncated tau causes early presynaptic dysfunction associated with Alzheimer's disease and other tauopathies","volume":"8","author":"Florenzano","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbadis.2019.165584_bb0650","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.neuron.2013.07.046","article-title":"Anti-tau antibodies that block tau aggregate seeding in vitro markedly decrease pathology and improve cognition in vivo","volume":"80","author":"Yanamandra","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.bbadis.2019.165584_bb0655","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/acn3.176","article-title":"Anti-tau antibody reduces insoluble tau and decreases brain atrophy","volume":"2","author":"Yanamandra","year":"2015","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.bbadis.2019.165584_bb0660","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s00702-014-1315-y","article-title":"Passive immunization targeting the N-terminal projection domain of tau decreases tau pathology and improves cognition in a transgenic mouse model of Alzheimer disease and tauopathies","volume":"122","author":"Dai","year":"2015","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.bbadis.2019.165584_bb0665","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13195-018-0341-7","article-title":"Tau passive immunization blocks seeding and spread of Alzheimer hyperphosphorylated tau-induced pathology in 3 \u00d7 Tg-AD mice","volume":"10","author":"Dai","year":"2018","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.bbadis.2019.165584_bb0670","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.bbrc.2016.12.101","article-title":"Passive immunization targeting the N-terminal region of phosphorylated tau (residues 68-71) improves spatial memory in okadaic acid induced tauopathy model rats","volume":"483","author":"Subramanian","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbadis.2019.165584_bb0675","first-page":"1327","article-title":"Interaction of tau with the neural plasma membrane mediated by tau's amino-terminal projection domain, J. Cell","volume":"131","author":"Brandt","year":"1995","journal-title":"Biol."},{"key":"10.1016\/j.bbadis.2019.165584_bb0680","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.neuron.2018.06.003","article-title":"Dendritic tau in Alzheimer\u2019s disease","volume":"99","author":"Ittner","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.bbadis.2019.165584_bb0685","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0210864","article-title":"Role of tau N-terminal motif in the secretion of human tau by end binding proteins","volume":"14","author":"Sayas","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2019.165584_bb0690","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1111\/jnc.13604","article-title":"Oligomerization of the microtubule-associated protein tau is mediated by its N-terminal sequences: implications for normal and pathological tau action","volume":"137","author":"Feinstein","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2019.165584_bb0695","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1006\/nbdi.2002.0549","article-title":"Caspase-9 activation and caspase cleavage of tau in the Alzheimer's disease brain","volume":"11","author":"Rohn","year":"2002","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbadis.2019.165584_bb0700","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.molmed.2017.04.001","article-title":"The exceptional vulnerability of humans to Alzheimer\u2019s disease","volume":"23","author":"Walker","year":"2017","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.bbadis.2019.165584_bb0705","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s12974-014-0152-0","article-title":"Epitope analysis following active immunization with tau proteins reveals immunogens implicated in tau pathogenesis","volume":"11","author":"Selenica","year":"2014","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.bbadis.2019.165584_bb0710","doi-asserted-by":"crossref","first-page":"3710","DOI":"10.1074\/jbc.RA118.001784","article-title":"An N-terminal motif unique to primate tau enables differential protein-protein interactions","volume":"293","author":"Stefanoska","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2019.165584_bb0715","doi-asserted-by":"crossref","unstructured":"F.M. LaFerla, K.N. Green, Animal models of Alzheimer disease, Cold Spring Harb Perspect Med. 2 (2012), pii: a006320. doi: https:\/\/doi.org\/10.1101\/cshperspect.a006320.","DOI":"10.1101\/cshperspect.a006320"},{"key":"10.1016\/j.bbadis.2019.165584_bb0720","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1001\/archneurol.2011.3354","article-title":"Alzheimer\u2019s disease neuroimaging initiative. Amyloid-\u03b2--associated clinical decline occurs only in the presence of elevated P-tau","volume":"69","author":"Desikan","year":"2012","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.bbadis.2019.165584_bb0725","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S1474-4422(11)70158-2","article-title":"Functional network disruption in the degenerative dementias","volume":"10","author":"Pievani","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bbadis.2019.165584_bb0730","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.neuron.2010.04.031","article-title":"Probing the biology of Alzheimer\u2019s disease in mice","volume":"66","author":"Ashe","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.bbadis.2019.165584_bb0735","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nrneurol.2013.223","article-title":"Alzheimer disease therapy\u2013moving from amyloid-\u03b2 to tau","volume":"9","author":"Giacobini","year":"2013","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.bbadis.2019.165584_bb0740","doi-asserted-by":"crossref","unstructured":"X.Q. Chen, W.C. Mobley, Alzheimer disease pathogenesis: insights from molecular and cellular biology studies of oligomeric A\u03b2 and tau species, Front Neurosci. 21 (2019) 13:659, doi: https:\/\/doi.org\/10.3389\/fnins.2019.00659.","DOI":"10.3389\/fnins.2019.00659"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443919303072?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443919303072?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T04:53:56Z","timestamp":1760417636000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443919303072"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":148,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S0925443919303072"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2019.165584","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"N-terminal tau truncation in the pathogenesis of Alzheimer's disease (AD): Developing a novel diagnostic and therapeutic approach","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2019.165584","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"165584"}}